Research Resource: Haploinsufficiency of Receptor Activity-Modifying Protein-2 (Ramp2) Causes Reduced Fertility, Hyperprolactinemia, Skeletal Abnormalities, and Endocrine Dysfunction in Mice
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Receptor activity-modifying protein-2 (RAMP2) is a single-pass transmembrane protein that can regulate the trafficking, ligand binding, and signaling of several G protein-coupled receptors (GPCR). The most well-characterized role of RAMP2 is in the regulation of adrenomedullin (AM) binding to calcitonin receptor-like receptor (CLR), and our previous studies using knockout mouse models support this canonical signaling paradigm. For example, Ramp2(-/-) mice die at midgestation with a precise phenocopy of the AM(-/-) and Calcrl(-/-) mice. In contrast, Ramp2(+/-) mice are viable and exhibit an expanded variety of phenotypes that are distinct from those of Calcrl(+/-) mice. Using Ramp2(+/-) female mice, we demonstrate that a modest decrease in Ramp2 expression causes severe reproductive defects characterized by fetal growth restriction, fetal demise, and postnatal lethality that is independent of the genotype and gender of the offspring. Ramp2(+/-) female mice also exhibit hyperprolactinemia during pregnancy and in basal conditions. Consistent with hyperprolactinemia, Ramp2(+/-) female mice have enlarged pituitary glands, accelerated mammary gland development, and skeletal abnormalities including delayed bone development and decreased bone mineral density. Because RAMP2 has been shown to associate with numerous GPCR, it is likely that signaling of one or more of these GPCR is compromised in Ramp2(+/-) mice, yet the precise identification of these receptors remains to be elucidated. Taken together, this work reveals an essential role for RAMP2 in endocrine physiology and provides the first in vivo evidence for a physiological role of RAMP2 beyond that of AM/CLR signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Hemizygous Ramp2 ϩ/Ϫ mice are viable, although they have severe reproductive defects, fetal growth restriction, enlarged pituitary glands, and a number of additional abnormalities (107).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [107]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Haploinsufficiency for RAMP2 caused significant skeletal defects, including delayed development and reduced mineral content and mineral density in femora of 18-wk-old females in comparison to WT controls.”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [107]
The cited source says what the claim attributes to it.
In the citing paper
“Tibiae of Ramp2 ϩ/Ϫ mice were significantly longer than those of WT controls.”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [107]
The cited source says what the claim attributes to it.
In the citing paper
“Ramp2 ϩ/Ϫ (hemizygous): delayed bone development, reduced mineral content, and mineral density.(107)”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [107]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M. (1998) · Nature · doi:10.1038/30666 · Cited by 2,134
Calcitonin Gene–Related Peptide Receptor Antagonist BIBN 4096 BS for the Acute Treatment of Migraine
Olesen, J., Diener, H.-C., Husstedt, I. W., Goadsby, P. J., Hall, D., Meier, U., Pollentier, S., & Lesko, L. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030505 · Cited by 1,189
Ho, T. W., Ferrari, M. D., Dodick, D. W., Galet, V., Kost, J., Fan, X., Leibensperger, H., Froman, S., Assaid, C., Lines, C., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61626-8 · Cited by 531
Ho, T. W., Mannix, L. K., Fan, X., Assaid, C., Furtek, C., Jones, C. J., Lines, C. R., & Rapoport, A. M. (2008) · Neurology · doi:10.1212/01.wnl.0000286940.29755.61 · Cited by 464
Amizuka, N., Warshawsky, H., Henderson, J. E., Goltzman, D., & Karaplis, A. C. (1994) · The Journal of cell biology · doi:10.1083/jcb.126.6.1611 · Cited by 454
Caron, K. M., & Smithies, O. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.615 · Cited by 346
Self-citationNovel Receptor Partners and Function of Receptor Activity-modifying Proteins
Christopoulos, A., Christopoulos, G., Morfis, M., Udawela, M., Laburthe, M., Couvineau, A., Kuwasako, K., Tilakaratne, N., & Sexton, P. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200629200 · Cited by 309
Wysolmerski, J. J., Philbrick, W. M., Dunbar, M. E., Lanske, B., Kronenberg, H., Karaplis, A., & Broadus, A. E. (1998) · Development · doi:10.1242/dev.125.7.1285 · Cited by 291
Adrenomedullin signaling is necessary for murine lymphatic vascular development
Fritz-Six, K. L., Dunworth, W. P., Li, M., & Caron, K. M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33302 · Cited by 261
Self-citation
Cited by
Amylin: Pharmacology, Physiology, and Clinical Potential
Hay, D. L., Chen, S., Lutz, T. A., Parkes, D. G., & Roth, J. D. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010629 · Cited by 400
Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles
Hay, D. L., & Pioszak, A. A. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103120 · Cited by 190
The Activity of Peptides of the Calcitonin Family in Bone
Naot, D., Musson, D. S., & Cornish, J. (2019) · Physiological Reviews · doi:10.1152/physrev.00066.2017 · Cited by 141
Adrenomedullin – new perspectives of a potent peptide hormone
Schönauer, R. A.-R., Els‐Heindl, S., & Beck‐Sickinger, A. G. (2017) · Journal of Peptide Science · doi:10.1002/psc.2953 · Cited by 89
Wootten, D., Lindmark, H., Kadmiel, M., Willcockson, H., Caron, K., Barwell, J., Drmota, T., & Poyner, D. (2013) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02202.x · Cited by 83
Self-citation
Metadata
- Authors
- Kadmiel, M., Fritz-Six, K., Pacharne, S., Richards, G. O., Li, M., Skerry, T. M., & Caron, K. M.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- University of Sheffield (GB)
- Academic Unit of Bone Biology (S.P., G.O.R., T.M.S.), Section of Musculoskeletal Science, School of Medicine and Biomedical Sciences, Beech Hill Road, Sheffield S10 2RX, United Kingdom
- Corresponding author
- Caron, Kathleen M.
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2011-07-01
- Volume
- 25
- Issue
- 7
- Pages
- 1244-1253
- ISSN
- 0888-8809 (ISSN-L)
- 1944-9917
- PMC
- PMC3125095
- OpenAlex
- W2058847639
- Semantic Scholar
- 678dc38cc9fe56c72dad5de26d48310872c8fa78
- Cited by
- 44
- References
- 32
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 2 · 2023: 2 · 2022: 1 · 2021: 2 · 2020: 3 · 2019: 4 · 2018: 3 · 2017: 4 · 2016: 5 · 2015: 3 · 2014: 2 · 2013: 2 · 2012: 7
- FWCI
- 1.46
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular Endocrinology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL091973, R01HL091973)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-056350, P30DK056350)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD46970, HD-060860, R01HD046970, R01HD060860)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- RAMP2, haploinsufficiency, adrenomedullin, calcitonin receptor-like receptor, G protein-coupled receptor regulation, hyperprolactinemia, fertility, skeletal abnormalities, bone mineral density, mammary gland development, pituitary gland, fetal growth restriction, endocrine dysfunction
- MeSH terms
- Animals, Animals, Newborn, Bone and Bones, Bone Development, Female, Femur, Fetal Death, Genes, Lethal, Hyperplasia, Hyperprolactinemia, Infertility, Female, Lumbar Vertebrae, Male, Mammary Glands, Animal, Mice, Inbred C57BL, Pituitary Gland, Pregnancy, Radiography, Tibia, Bone Density, Mice, Knockout, Mice, Mice, 129 Strain, Haploinsufficiency, Receptor Activity-Modifying Protein 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Research Resource: Haploinsufficiency of Receptor Activity-Modifying Protein-2 (Ramp2) Causes Reduced Fertility, Hyperprolactinemia, Skeletal Abnormalities, and Endocrine Dysfunction in Mice. https://app.cochat.ai/papers/10.1210/me.2010-0400
- The paper
- Kadmiel, M., Fritz-Six, K., Pacharne, S., Richards, G. O., Li, M., Skerry, T. M., & Caron, K. M. (2011). Research Resource: Haploinsufficiency of Receptor Activity-Modifying Protein-2 (Ramp2) Causes Reduced Fertility, Hyperprolactinemia, Skeletal Abnormalities, and Endocrine Dysfunction in Mice. Molecular Endocrinology. https://doi.org/10.1210/me.2010-0400
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.